Macrolide Antibiotics and Survival in Patients With Acute Lung Injury
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs (K07 CA138772)
- National Cancer Institute (K07 CA138772)
This publication has 34 references indexed in Scilit:
- Immunomodulatory Effects of Macrolide Antibiotics – Part 1: Biological MechanismsRespiration, 2010
- Applying Propensity Score Methods in Medical Research: Pitfalls and ProspectsMedical Care Research and Review, 2010
- Adjunctive Therapy in Community-Acquired PneumoniaSeminars in Respiratory and Critical Care Medicine, 2009
- Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Macrolides as immunomodulatory medications for the therapy of chronic lung diseasesCurrent Opinion in Pharmacology, 2008
- Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysisBMJ, 2007
- Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndromeCritical Care Medicine, 2002
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordinationIntensive Care Medicine, 1994
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983